Cell line · CVCL_1759
TE-1
Cancer cell line, Homo sapiens. Esophageal squamous cell carcinoma. 48 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Cite this record
ConductScience Library. TE-1. Cell lines, record CVCL_1759. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_1759
On this page
Cell line
As Cellosaurus gives it.
- Name
- TE-1
- Accession
- CVCL_1759
- RRID
- RRID:CVCL_1759
- Synonyms
- TE1
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 58Y
- Category
- Cancer cell line
- Diseases
- Esophageal squamous cell carcinoma (NCIt C4024); Squamous cell carcinoma of the esophagus (ORDO Orphanet_99977)
- Derived from
- Esophagus (in situ)
- Entry created
- 2012-04-04
- Entry updated
- 2025-04-10
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers48
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Inhibition of the AT-Hook DNA-Binding Domain Attenuates HMGA2-Mediated Epithelial Mesenchyme Transition in Esophageal Cancer Cells. | Int J Mol Sci | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Elevated CHAF1A Suppresses Type I Interferon Production and Causes Immunotherapy Resistance in Esophageal Squamous Cell Carcinoma. | Cancer Immunol Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Multiomic characterization of response and resistance to neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma. | Transl Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| The AGPS regulatory variant rs113671272 confers esophageal squamous cell carcinoma susceptibility through allele-specific MEIS3 binding and NF-κB activation in Chinese populations. | EBioMedicine | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Lactylome Reprogramming Mediates Therapeutic Response and Adaptation to Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma. | Mol Cell Proteomics | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A Noncanonical RNA-Binding Function of NQO1 Drives Angiogenesis in Esophageal Squamous Cell Carcinoma via Extracellular Vesicle-Mediated AGRN Transfer. | Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| NIPAL1 Drives a Metabolic-Epigenetic Feedback Loop to Promote Lactate-Mediated Immune Evasion in Esophageal Cancer. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Spatio-Temporal Proteomic Landscape Reveals Early Warning Signals of Esophageal Squamous Cell Carcinoma Progression. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Characterization of tertiary lymphoid structure identifies competitive binding of CD40 and STING with TRAF2 driving IRF4-mediated B cell activation in esophageal squamous cell carcinoma. | Cancer Gene Ther | 2025 | Its Methods give the RRID and name the line | PubMed | |
| NUDT21 lactylation reprograms alternative polyadenylation to promote cuproptosis resistance. | Cell Discov | 2025 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 48
See all 48 papersRelatives4
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | HyCyte TE-1 KO-hCHST1 | CVCL_E1MX | Cell lines | |
| Derived from it | HyCyte TE-1 KO-hTFAP2B | CVCL_F4EE | Cell lines | |
| Derived from it | HyCyte TE-1 stable cell line for hCHST1 overexpression | CVCL_F4VX | Cell lines | |
| Derived from it | TE-1R | CVCL_C3M0 | Cell lines |
Cell banks6
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ABM | T9161 | ABM | |
| BCRJ | 0371 | BCRJ | |
| CLS | 305060 | CLS | |
| KCB | KCB 200737YJ | Cellosaurus | |
| RCB | RCB1894 | RCB | |
| TKG | TKG 0252 | Cellosaurus |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_1759
GET https://conductscience.org/api/cell-lines/v1/CVCL_1759/papers?page=2